2011 Healthcare Provider Prospecting Sales 
Cadensee
JULY 26, 2021
We established a wholly owned subsidiary in the US and we have an office in San Diego with sales and marketing personnel. So, this was a prospective, randomized, double blind, placebo-controlled study. Which oftentimes, the sales are running very fast and the operations isn't there to support it. It's wonderful.
Pharmaceutical Technology
JANUARY 6, 2023
This class-action litigation specifically focused on a 2011 licensing agreement between the two companies. In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000. In September, Novartis announced its plans to petition the US Supreme Court to reverse the aforementioned decision.
Expert insights. Personalized for you.
52 
Let's personalize your content